🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to assess the relative bioavailabilit...
Status
Completed
Location
Teva Investigational Site 12141
Start Date
2025-03-10
Trial ID
NCT06911567
Treatments Being Tested
The purpose of this study is to evaluate the amount of GLPG0187 present in ...
Status
Completed
Location
SGS Stuivenberg
Start Date
2012-01
Trial ID
NCT01580644
Treatments Being Tested
Clinical investigation of anti-psoriatic efficacy and atrophy...
Status
Completed
Location
proDERM GmbH
Start Date
2014-03
Trial ID
NCT02111499
Treatments Being Tested
To determine whether new 80 mg atorvastatin tablets are bioequivalent to 80...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-07
Trial ID
NCT00917644
Treatments Being Tested
The goal of this clinical trial is to evaluate whether a synbiotic dietary ...
Status
Not Yet Recruiting
Location
Department of Pharmaceutical Botany, Univeristy of Medicine and Pharmacy "Iuliu Hațieganu", 23 Gheorghe Marinescu Street, 3rd Floor, Cluj-Napoca, Romania
Start Date
2026-04
Trial ID
NCT07475299
This study is designed to compare the incremental area under the curve from...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-05-20
Trial ID
NCT02428699
Treatments Being Tested
The primary purpose is to demonstrate the bioequivalence of naproxen admini...
Status
Completed
Location
Research Site
Start Date
2011-09
Trial ID
NCT01331993
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy, and tolerabi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT00741884
This is a single centre, open-label, randomised, single dose, three-period,...
Status
Completed
Location
Simbec Research Ltd.
Start Date
2017-05-22
Trial ID
NCT03178214
Treatments Being Tested